Font Size: a A A
Keyword [Basal cell]
Result: 101 - 120 | Page: 6 of 9
101. The Expression And Significance Of DAB2IP In Basal Cell Carcinoma Of The Skin
102. The Contribution Of Nerve Growth Factor Receptor NGFR To The Pathogenesis Of COPD
103. Screening Of Differential MRNA And LncRNA Related To Skin Basal Cell Carcinogenesis And Analysis Of The Biological Function Of CASC15
104. Retrospective Analysis For Clinical And Histopathological Characteristics Of Basal Cell Carcinoma In 153 Patients
105. Retrospective Analysis For Clinical And Histopathological Characteristics Of Facial Basal Cell Carcinoma In 191 Patients
106. Clinical And Pathological Analysis Of 597 Cases Of Facial Skin Malignant Tumor
107. Study On Non-invasive Detection Methods For Defining The Margins Of Basal Cell Carcinoma Before Operation
108. Clinical Application Of Slender Narrow Pedicle Flap In The Treatment Of Basal Cell Carcinoma Of The Trunk And Extremities
109. The Relationship And The Expression Of P62 And Casepase-8 In Basal Cell Carcinoma
110. Dermatoscope Performance In Basal Cell Carcinoma And Correlation Research With Histopathological Changes
111. Study On The Expression And Function Of FAP In The Eyelid Basal Cell Carcinoma And Benign Tumor Associated Fibroblasts
112. Expression And Significance Of HSP60 And HSP90 In Basal Cell Carcinoma Of Skin
113. Expression And Significance Of IL-23/Th17 Related Cytokines In Basal Cell Carcinoma
114. Expression Of DAB2IP In Cutaneous Squamous Carcinoma And Basal Cellcarcinoma And Its Mechanism Of Invasion Of Squamous Cellcarcinoma
115. Gene Detection And Analysis In Duchenne Muscular Dystrophy And Basal Cell Nevus Syndrome
116. Clinical Characteristics And Genetic Analysis Of Nevoid Basal Cell Carcinoma Syndrome With Epilepsy
117. Multiple Primary Malignant Tumors:A Case Report And Literature Review
118. Clinical Analysis Of 238 Cases Of Eyelid Tumors
119. Clinical And Pathological Analysis Of 29 Patients Had More Than One Cutaneous Malignant Tumors
120. Retrospective Analysis And Quality Of Life Assessment Of Malignant Scalp Tumors
  <<First  <Prev  Next>  Last>>  Jump to